Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other financing activities: 2012-2024

  • Fennec Pharmaceuticals' Other financing activities was N/A to $1.7 million in Q1 2024 from the same period last year, while for Mar 2024 it was $2.6 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 57900.00% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Other financing activities of $1.7 million as of Q1 2024, which was up 787.76% from $196,000 recorded in Q4 2022.
  • Over the past 5 years, Fennec Pharmaceuticals' Other financing activities peaked at $1.7 million during Q1 2024, and registered a low of $117,000 during Q3 2020.
  • For the 2-year period, Fennec Pharmaceuticals' Other financing activities averaged around $968,000, with its median value being $968,000 (2022).